HIV

HIV cell
#HIV #Immunity #Immunology / Virology & Vaccines #National Institute of Allergy and Infectious Diseases

Study suggests ways to improve future HIV vaccine candidates

An effective HIV vaccine may need to prompt strong responses from CD8+ T cells to protect people from acquiring HIV, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID). The researchers drew comparisons between the immune system activity of past HIV… Read More

#News

Pathology data for HIV
#Biorepository #Data #HIV #National Institutes of Health (NIH) #Pathology #Proscia #The AIDS and Cancer Specimen Resource

Pathology data to advance discovery for HIV cancer patients 

The AIDS and Cancer Specimen Resource (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) established in 1994 and funded by the National Institutes of Health, National Cancer Institute, is using software from Proscia to encourage scientific exploration and discovery in cancer in PLWH.  … Read More

#News

Chinese flag
#China #HIV #Regulatory #ViiV Healthcare

Chinese regulator approves complete HIV-1 injectable

The National Medical Products Administration (NMPA) of China has approved ViiV Healthcare’s Vocabria (cabotegravir injection) in combination with Janssen's Rekambys (rilpivirine long-acting injection) for the treatment of HIV-1 infection. Cabotegravir injection and tablets were approved in China in July 2023. Cabotegravir injection is indicated in adults who are virologically suppressed,… Read More

#News #Regulatory

HIV test
#FDA #HIV #Monoclonal antibodies #Theratechnologies

Results from HIV mAB intramuscular administration study 

Theratechnologies, a biopharmaceutical company focused on the development and commercialisation of innovative therapies, has announced results from a study evaluating an intramuscular (IM) method of administration for Trogarzo (ibalizumab-uiyk), a monoclonal antibody antiretroviral therapy (ART) for the treatment of heavily treatment-experienced adults with multidrug-resistant (MDR) HIV-1 infection failing their… Read More

#News

#ABL Diagnostics #Collaboration #Cytomegalovirus #Diagnostics #HIV #Human Papillomavirus #Infectious diseases #Laboratory #Microbiology #Roche #Tuberculosis #Viral hepatitis

Roche and ABL Diagnostics expand to South African laboratories  

Roche Diagnostics and ABL Diagnostics have launched a distribution partnership which will see Roche supplying ABLD products to South African laboratories.   Roche now has exclusive rights to distribute products, including the ABL DeepChek assays to laboratories implementing microbiology applications. These applications include HIV, Tuberculosis, Cytomegalovirus, Viral… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

Podcast: This week’s drug discovery highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Each of our top five stories this week exemplify the scientific curiosity that fuels the drug… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

This week in drug discovery (24-28 April)

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to… Read More

#News

CAR-T cell
#CAR-T #Cell therapy #HIV #University of California

Researchers hope to cure HIV using CAR-T cells

University of California researchers have dosed the second participant in their clinical trial to identify a potential cure for HIV utilising CAR-T cell therapy. The first participant was dosed with anti-HIV duoCAR T cells at UC Davis Medical Center in mid-August. The trial is the first-in-human… Read More

#News

#Antibiotics #Cancer vaccine #Drug discovery #HIV #Long Covid #Malaria

This week in drug discovery (10-14 April)

News round-up for 10-14 April by DDW Digital Content Editor Diana Spencer. The headlines getting our attention this week all represent significant breakthroughs in the treatment of various diseases and could make a huge difference to the lives of these patients. Perhaps most significantly,… Read More

#News

Cardiovascular system
#Cardiovascular disease #Heart disease #HIV #National Institutes of Health (NIH) #Statins

Daily statin reduces the risk of cardiovascular disease in HIV

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV. This was the first large-scale clinical study to test a primary cardiovascular prevention strategy in… Read More

#Editor's Choice #News

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

New episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Our news highlights this week focus on research into vaccines, with… Read More

#News

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

This week in drug discovery (20-24 February)

News round-up for 20-24 February by DDW Digital Content Editor Diana Spencer.  Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep A and HIV. Particularly interesting is the announcement that a new class… Read More

#News

Vaccine
#AELIX Therapeutics #HIV #Immune response #Immunology / Virology & Vaccines #Phase II trial #T cell activation

HIV combination regimen could lead to viral remission

AELIX Therapeutics has announced positive results from its randomised, placebo-controlled Phase IIa therapeutic HIV vaccine and immune modulator combination clinical trial.  The AELIX-003 trial evaluated the safety, tolerability, immunogenicity and efficacy of AELIX’s HTI T-cell therapeutic HIV vaccine in combination with Gilead’s investigational Toll-Like Receptor 7 (TLR7)… Read More

#News #Trending News

T cells
#HIV #Immunocore #Phase I trial #T cell activation #T cell receptor (TCR)

Positive early data for first soluble TCR therapy for HIV

A Phase I safety and pharmacodynamic activity trial shows IMC-M113V, the first soluble T cell receptor (TCR) therapy for people living with HIV, is well tolerated.  Immunocore presented the findings at the Conference on Retroviruses and Opportunistic Infection (CROI).  The bispecific soluble TCR therapy built… Read More

#News #Trending News

Vaccine
#HIV #Immunology / Virology & Vaccines #Janssen #National Institute of Allergy and Infectious Diseases #Phase III trial

Experimental HIV vaccine safe but ineffective

An investigational HIV vaccine regimen was safe but did not provide protection against HIV, an independent data and safety monitoring board (DSMB) has determined.  The regimen was tested among men who have sex with men (MSM) and transgender people. The HPX3002/HVTN 706, or ‘Mosaico’, Phase III clinical… Read More

#News

#Boehringer Ingelheim #Cancer research #Collaboration #Diabetes #Drug development #Drug discovery #Eli Lilly #HIV #Lung cancer #Neurodevelopmental disorders #Precision medicine #Rare disease

DDW Highlights podcast shares five new stories

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news.  ‘Teamwork makes the dream work’ this week, with the launch of… Read More

#News